Scinai Immunotherapeutics (SCNI) Accounts Payables (2015 - 2026)
Scinai Immunotherapeutics (SCNI) reported Accounts Payables of $779000.0 for Q1 2026, up 91.4% sequentially from $407000.0 in Q4 2025.
Scinai Immunotherapeutics (SCNI) Accounts Payables (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 12 years of Accounts Payables data on file, last reported at $779000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $779000.0; the trailing twelve-month figure through Mar 2026 stood at $779000.0 (changed N/A YoY), and the FY2025 full-year result was $407000.0, up 8.24% from the prior year.
- Accounts Payables advanced to $779000.0 in Q1 2026, from $407000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.3 million in Q1 2023 to a low of $297000.0 in Q3 2022.
- A 5-year average of $678333.3 and a median of $651000.0 in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 99.98% in 2022 and jumped 83.84% in 2023, its largest moves.
- Tracing SCNI's Accounts Payables over 5 years: stood at $716000.0 in 2022, then slipped by 25.28% to $535000.0 in 2023, then dropped by 29.72% to $376000.0 in 2024, then advanced by 8.24% to $407000.0 in 2025, then surged by 91.4% to $779000.0 in 2026.
- Business Quant data shows SCNI's Accounts Payables at $779000.0 in Q1 2026, $407000.0 in Q4 2025, and $659000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 779,000.00 |
| Dec 31, 2025 | 407,000.00 |
| Jun 30, 2025 | 659,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 430,000.00 |
| Jun 30, 2024 | 658,000.00 |
| Mar 31, 2024 | 928,000.00 |
| Dec 31, 2023 | 535,000.00 |
| Sep 30, 2023 | 546,000.00 |
| Jun 30, 2023 | 651,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 716,000.00 |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 588,000.00 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 999,000.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 2.64 Bn |
| Mar 31, 2021 | 2.09 Bn |
| Dec 31, 2020 | 1.87 Bn |